MINI FUTURE OPTIONSSCHEIN - EDWARDS LIFESCIENCES | Real-time Bid/Ask 12:45:48 20/05/2024 pm IST | ||
| 4.19 EUR / 4.27 EUR | +0.24% |
|
| Current month | -10.21% | ||
| 1 month | -5.38% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 20/24/20 | 4.2 | -0.47% |
| 17/24/17 | 4.22 | +2.93% |
| 16/24/16 | 4.1 | -0.73% |
| 15/24/15 | 4.13 | -7.81% |
| 14/24/14 | 4.48 | -3.24% |
Delayed Quote Börse Stuttgart
Last update May 20, 2024 at 12:19 pm IST
More quotesStatic data
| Product type | Knock-Out mit Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | J.P. Morgan |
| WKN | JK1U7R |
| ISIN | DE000JK1U7R8 |
| Date issued | 06/02/2024 |
| Strike | 134.8 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 4.54 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 4.7 € |
|---|---|
| Lowest since issue | 3.65 € |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
89.14
USD
Average target price
95.9
USD
Spread / Average Target
+7.59%
- Stock Market
- Certificates
- Certificat
